Table V.
| Allele | Frequency in Caucasian populations | Cancer risks |
|---|---|---|
| P1*A | 0.65 | Cisplatin resistance |
| P1*B | 0.262 | Favorable response to cisplatin. Increased susceptibility to lung, bladder and testicular tumors |
| P1*C | 0.068 | Predominant genotype in malignant glioma. Protective for breast cancer |